Immuron Limited (IMRN): Price and Financial Metrics
Immuron Limited (IMRN)
Today's Latest Price: $7.11 USD
Updated Jan 27 3:07pm
Add IMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
IMRN Stock Summary
- For IMRN, its debt to operating expenses ratio is greater than that reported by merely 0.52% of US equities we're observing.
- With a year-over-year growth in debt of -100%, Immuron Ltd's debt growth rate surpasses just 0% of about US stocks.
- As for revenue growth, note that IMRN's revenue has grown 141.24% over the past 12 months; that beats the revenue growth of 95.9% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Immuron Ltd, a group of peers worth examining would be GIGM, GENC, FEIM, UG, and LKCO.
- IMRN's SEC filings can be seen here. And to visit Immuron Ltd's official web site, go to www.immuron.com.au.
IMRN Stock Price Chart Interactive Chart >
IMRN Price/Volume Stats
| Current price | $7.11 | 52-week high | $28.99 |
| Prev. close | $7.54 | 52-week low | $1.55 |
| Day low | $6.91 | Volume | 83,814 |
| Day high | $7.46 | Avg. volume | 52,398 |
| 50-day MA | $7.07 | Dividend yield | N/A |
| 200-day MA | $6.94 | Market Cap | 40.32M |
Immuron Limited (IMRN) Company Bio
Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.
Loading social stream, please wait...